Compare TLSI & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSI | ELME |
|---|---|---|
| Founded | 2010 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.3M | 271.5M |
| IPO Year | N/A | N/A |
| Metric | TLSI | ELME |
|---|---|---|
| Price | $5.43 | $2.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $11.50 | ★ $14.25 |
| AVG Volume (30 Days) | 118.9K | ★ 6.2M |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,207,000.00 | ★ $246,959,000.00 |
| Revenue This Year | $55.47 | N/A |
| Revenue Next Year | $40.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | 3.10 |
| 52 Week Low | $3.42 | $2.70 |
| 52 Week High | $7.95 | $18.08 |
| Indicator | TLSI | ELME |
|---|---|---|
| Relative Strength Index (RSI) | 38.68 | 6.82 |
| Support Level | $5.24 | $2.70 |
| Resistance Level | $5.87 | $3.11 |
| Average True Range (ATR) | 0.41 | 0.14 |
| MACD | -0.09 | -0.50 |
| Stochastic Oscillator | 18.35 | 1.61 |
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.